Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/15/2025
NHSA Unveils Three-Year Plan to Accelerate BMI Fund Clearing and Settl...
12/15/2025
BroadenBio Raises ~CNY 100M in Series A+ to Advance Oncology and Autoi...
12/15/2025
Everest Signs Dual Strategic Deals With Hasten to Expand Commercial Re...
12/15/2025
Insilico Licenses AI-Designed Anemia Drug ISM4808 to TaiGen for Greate...
12/15/2025
Sino Biopharm Wins NMPA Approval for FIC Triple CDK Inhibitor in Breas...
12/15/2025
InnoCare Secures NMPA Approval for Pan-TRK Inhibitor Zurletrectinib
12/15/2025
Qilu Wins Approval for China's First Fully Human Anti-EGFR Antibody
12/15/2025
AusperBio Reports Promising Phase 2a Results for AHB-137 in Chronic He...
12/15/2025
Qilu Advances GSPT1 Degrader ADC Program, PCT Patent Reveals
12/15/2025
KYinno Raises ~CNY 250M in Series B to Advance Multispecific Antibod...
12/15/2025
CDE Seeks Comments on Draft Technical Guidelines for Generic Ophthalmi...
12/15/2025
CDE Solicits Comments on First Batch of ICH M13A Low-Risk Formulation ...
12/12/2025
InnoCare Pharma Wins NMPA Approval for Next-Gen TRK Inhibitor Zurletre...
12/12/2025
Ascletis' Acne Drug Denifanstat Enters NMPA Review After NDA Acceptanc...
12/12/2025
CMS's NDA for Innovative Stroke Drug Y-3 for Injection Accepted in Ch...
12/12/2025
Abraham Accords Partners Could Help the U.S. Reduce Pharma Dependence ...
12/12/2025
Sidera Secures $109M in Major Series A and Global Rights to China-Orig...
12/12/2025
Recent Executive Moves
12/11/2025
Formation Bio Secures Global Rights to Lynk Pharma's CNS-Targeted TYK2...
12/11/2025
China Pushes Private Insurance to Cover High-Cost Innovative Drugs as ...
12/11/2025
Syneron Secures ~$100M to Advance Macrocyclic Peptide Drug Pipeline
12/11/2025
China Approves Boehringer Ingelheim's Jascayd for Progressive Pulmonar...
12/11/2025
Zealand and OTR Thera Form $2.5B Alliance to Develop Next-Gen Metabo...
12/11/2025
Kelingyuan Reports Early Tumor Responses for Novel HER2-Targeted ADC S...
12/11/2025
Hengrui Launches Phase 1/2 Trial of Subcutaneous PD-1/VEGF BsAb SHR-46...
12/11/2025
Forward Pharma Reports Promising Early Data for Oral SERD FWD1802
12/11/2025
China Approves Sanofi's Qfitlia (fitusiran) for Severe Hemophilia
12/11/2025
73 Mainland Chinese Biotech/MedTech Firms Flock to Hong Kong for IPO...
12/11/2025
China Tightens Oversight as Domestic Innovators Dominate November Drug...
12/11/2025
Chinese Biopharma Sector Posts 22 Financings in November as In Vivo C...
Page:
1
/
805
Total number of articles:
24134
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit